Skip to main content

Table 5 Factors associated with abdominal obesity presented separately for 86 women and 104 men with T1D

From: Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study

 

Abdominal obesity

Women

Men

COR (95% CI)

P

AOR (95% CI)

P a

COR (95% CI)

P

AOR (95% CI)

P b

Age (per year)

1.00 (0.96–1.05)

0.87

0.99 (0.94–1.04)

0.63

1.05 (0.98–1.13)

0.20

1.05 (0.97–1.12)

0.22

Diabetes duration (per year)

1.01 (0.97–1.05)

0.67

–

–

1.01 (0.96–1.07)

0.62

–

–

MSCc

 High

13 (1.6–107)

0.017

18.4 (1.9–181)

0.013

0.7 (0.1–3.2)

0.62

–

–

 Intermediate

9.9 (1.1–88)

0.040

10.3 (1.0–107)

0.051

0.3 (0.03–3.0)

0.32

–

–

 Low

1

 

1

 

1

 

–

–

 Hypoglycaemia

0.8 (0.1–7.2)

0.81

–

–

4.4 (0.4–48.3)

0.22

–

–

 Smoking

0.8 (0.1–7.4))

0.83

–

–

1.2 (0.1–10.8)

0.87

–

–

 Physical inactivity

2.6 (0.6–10.9)

0.18

–

–

–

> 0.99

–

–

 Depression

1.0 (0.2–5.6)

0.97

–

–

2.9 (0.5–16.2)

0.23

–

–

 Alexithymia

2.0 (0.6–6.2)

0.25

–

–

5.2 (1.1–24.9)

0.041

5.2 (1.1–24.9)

0.041

 Antidepressants

8.3 (1.9–36.9)

0.006

12.2 (2.0–73.6)

0.006

–

> 0.99

–

–

  1. N = a86/b104; a,b Multiple logistic regression analysis (Backward Wald): variables with p-values ≤ 0.10 for the CORs and age were included in the analyses; Nagelkerke R Square: a 0.299/ b0.082; Hosmer and Lemeshow test: a0.639/b0.085. cMidnight salivary cortisol